RxDoctor Payments Data

Whitney Martin, PA

Physician Assistant · Missoula, MTNPI 1316049695

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,122 of the $3,443 with a category attached, or 61.6%. 8 manufacturers reported payments, led by Axonics, Inc. at 54.2% of the total. Among physician assistant clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,443in general payments, 2019–2025

Across 46 payments — averaging $74.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axonics, Inc.$2K
  • Medtronic$1K
  • AbbVie$251
  • Astellas Pharma US Inc$129
  • 180 Medical, Inc.$17
  • GRT US Holding, Inc.$15
  • plus $27 from 2 others

What the payments were for

  • Travel & lodging$2,12262%
  • Food & beverage$1,22035%
  • Education$1013%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Axonics, Inc.12$1,868
Medtronic14$1,136
AbbVie(2 entities)11$251
Astellas Pharma US Inc5$129
180 Medical, Inc.1$17
GRT US Holding, Inc.1$15
Profound Medical Corp.1$14
Coloplast1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,443 in reported general payments places this provider in the 95th percentile of 626 physician assistant providers in Montana.

See all physician assistant providers in Montana

Medicare billing

Part B allowed, 2024
$19,290
Medicare patients
132
Services billed
411

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron143$103,330
GemtesaVibegron76$54,200
Estradiol53$4,635
Solifenacin Succinate56$1,749
Methenamine Hippurate21$1,564
Tamsulosin Hcl46$1,039
Fesoterodine Fumarate ErFesoterodine Fumarate23$995
NitrofurantoinNitrofurantoin Macrocrystal15$676
Oxybutynin Chloride ErOxybutynin Chloride32$523
Oxybutynin Chloride11$284
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst18$278
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim25$166
Cephalexin21$133

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$129$103,330143 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 626 physician assistant providers in Montana.

Other physician assistant in Missoula

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →